Authors:
CLAYMAN GL
ELNAGGAR AK
LIPPMAN SM
HENDERSON YC
FREDERICK M
MERRITT JA
ZUMSTEIN LA
TIMMONS TM
LIU TJ
GINSBERG L
ROTH JA
HONG WK
BRUSO P
GOEPFERT H
Citation: Gl. Clayman et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(6), 1998, pp. 2221-2232
Authors:
ROTH JA
SWISHER SG
MERRITT JA
LAWRENCE DD
KEMP BL
CARRASCO CH
ELNAGGAR AK
FOSSELLA FV
GLISSON BS
HONG WK
KHURL FR
KURIE JM
NESBITT JC
PISTERS K
PUTNAM JB
SCHRUMP DS
SHIN DM
WALSH GL
Citation: Ja. Roth et al., GENE-THERAPY FOR NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF A PHASE-I TRIAL OF ADENOVIRAL P53 GENE REPLACEMENT, Seminars in oncology, 25(3), 1998, pp. 33-37
Authors:
MERRITT JA
CLAYMAN GL
SWISHER S
NEMUNAITIS J
ELNAGGAR A
GINSBERG L
LAWRENCE D
TIMMONS T
HENDERSON Y
FREDERICK M
CONNORS D
HUTCHISON A
BRUSO P
ROTH JA
SHULKIN A
WEILL D
WAIT J
Citation: Ja. Merritt et al., CLINICAL-PHASE-I EXPERIENCE WITH INGN-201 (AD-P53) IN NONSMALL CELL LUNG-CANCER AND HEAD AND NECK-CANCER, Cancer gene therapy, 4(6), 1997, pp. 1-1
Authors:
MERRITT JA
CLAYMAN G
SCHWISHER S
NEMUNAITIS J
ELNAGGAR A
TIMMONS T
LAWRENCE D
KEMP B
FREDERICK M
CONNORS D
BRUSO P
GOEPFERT H
HONG WK
ROTH JA
Citation: Ja. Merritt et al., CLINICAL GENE-THERAPY STRATEGIES - PHASE-I PHASE-II RESULTS WITH ADENOVIRAL P53 (INGN-201) GENE-TRANSFER IN ADVANCED HEAD AND NECK AND NON-SMALL-CELL LUNG CANCERS/, Cancer gene therapy, 4(5), 1997, pp. 330-330
Authors:
QUAN WDY
DEAN GE
SPEARS L
SPEARS CP
GROSHEN S
MERRITT JA
MITCHELL MS
Citation: Wdy. Quan et al., ACTIVE SPECIFIC IMMUNOTHERAPY OF METASTATIC MELANOMA WITH AN ANTIIDIOTYPE VACCINE - A PHASE I II TRIAL OF I-MEL-2 PLUS SAF-M/, Journal of clinical oncology, 15(5), 1997, pp. 2103-2110
Citation: Dw. Leger et al., ADULT PERCEPTION OF EMOTION INTENSITY IN HUMAN INFANT CRIES - EFFECTSOF INFANT AGE AND CRY ACOUSTICS, Child development, 67(6), 1996, pp. 3238-3249